CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Pharmaceutical Preparations
Latest Price
$2.22
TTM P/E
3.96
Normalized P/E
--
Div Yield
--
Book Value
0.79
P/B Ratio
2.81
Valuation metrics
adjust assumptions →EPS: $0.07
Book value / share: $1.83
Formula: √(22.5 × EPS × BVPS)
Graham Number
$1.70
24% downside
EPS: $0.07
Target P/E: 4×
Formula: EPS × P/E
P/E Fair Value
$0.28
87% downside
Institutional Ownership
14.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.89M | $2.0M | 3.61% | +2.07M | 2026-06-30 |
| BlackRock, Inc. | 2.62M | $1.0M | 2.43% | +280.6K | 2026-06-30 |
| JANE STREET GROUP, LLC | 1.97M | $1.0M | 1.82% | +1.85M | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.29M | -- | 1.19% | +1.03M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.17M | -- | 1.09% | +602.7K | 2026-06-30 |
| UBS Group AG | 1.13M | -- | 1.05% | +956.3K | 2026-06-30 |
| XTX Topco Ltd | 638.3K | -- | 0.59% | +607.7K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 571.3K | -- | 0.53% | +274.3K | 2026-06-30 |
| STATE STREET CORP | 516.1K | -- | 0.48% | +376.0K | 2026-06-30 |
| Cygnus Capital Advisors, LLC | 246.5K | -- | 0.23% | +235.0K | 2026-06-30 |